NCT04576182

Brief Summary

This study will explore the mechanisms of change that are activated when individuals receive a treatment that targets their weakness and the mechanisms activated when the treatment capitalize on their strength. Patients will be assigned to one of two types of psychotherapies in treating people with a major depression disorder, expressive-supportive vs. emotion-focused treatment. Their ability to benefit from treatment based on their pre-treatment levels of insight and emotional processing will be examined. This is a four-month protocol, with a 2 year follow up period.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
124

participants targeted

Target at P75+ for not_applicable major-depressive-disorder

Timeline
12mo left

Started Nov 2020

Longer than P75 for not_applicable major-depressive-disorder

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress84%
Nov 2020May 2027

First Submitted

Initial submission to the registry

September 26, 2020

Completed
10 days until next milestone

First Posted

Study publicly available on registry

October 6, 2020

Completed
2 months until next milestone

Study Start

First participant enrolled

November 29, 2020

Completed
6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2026

Expected
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2027

Last Updated

May 7, 2026

Status Verified

May 1, 2026

Enrollment Period

6 years

First QC Date

September 26, 2020

Last Update Submit

May 3, 2026

Conditions

Keywords

PsychotherapyMechanism of changesupportive-expressive treatmentEmotion-Focused TherapyPsychodynamic psychotherapyInsightemotional processing

Outcome Measures

Primary Outcomes (1)

  • Weekly change in Hamilton rating scale for depression (HRSD)

    A 17-item clinically administered measure assessing the severity of depression. Higher scores indicate worse outcome.

    up to 16 weeks.

Secondary Outcomes (4)

  • Weekly change in Beck Depression Inventory (BDI)

    up to 16 weeks

  • Weekly change in Outcome Questionnaire (OQ)

    up to 16 weeks

  • Trajectories of change in Inventory of Interpersonal Problems (IIP-32)

    At intake and 6 times during the treatment (weeks 1, 2, 4, 8, 12, 16)

  • trajectories of change in Quality of Life Enjoyment and Satisfaction- Short Version (Q-LES-Q)

    At intake and 6 times during the treatment (weeks 1, 2, 4, 8, 12, 16)

Study Arms (2)

Supportive-Expressive

EXPERIMENTAL

Participants will receive supportive-expressive treatment for 16 weeks.

Behavioral: Supportive-expressive treatment

Emotion-Focused

EXPERIMENTAL

Participants will receive Emotion-Focused treatment for 16 weeks.

Behavioral: Emotions-Focused treatment

Interventions

Sixteen weeks of a time-limited psychodynamic therapy adapted for depression that includes the use of expressive techniques, such as interpretation, confrontation, clarification and the use of supportive techniques, such as affirmation and empathic validation. This treatment postulates insight as its core mechanism of change.

Supportive-Expressive

Sixteen weeks of a brief experiential therapy for depression that combine client-centered relational elements (unconditional positive regard, congruence, and empathy) with marker-guided experiential interventions designed to facilitate and deepen emotional processing and emotion regulation.

Emotion-Focused

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Meeting major depressive disorder diagnostic criteria using the structured clinical interviews for Diagnostic and Statistical Manual of Mental Disorders-5 and scoring more than 14 on the 17-item Hamilton rating scale for depression at two evaluations (one week apart) (Hamilton, 1967).
  • If on medication, patients' dosage must be stable for at least three months prior to entering the study, and they must be willing to maintain stable dosage for the duration of treatment
  • Age between 18 and 65
  • Hebrew language fluency
  • Provision of written informed consent.

You may not qualify if:

  • Current risk of suicide or self-harm
  • current substance abuse disorders
  • current or past schizophrenia or psychosis, bipolar disorder, or severe eating disorder requiring medical monitoring
  • history of organic mental disease
  • currently in psychotherapy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Haifa

Haifa, Israel

RECRUITING

Related Publications (1)

  • Zilcha-Mano S, Shahar B, Fisher H, Dolev-Amit T, Greenberg LS, Barber JP. Investigating patient-specific mechanisms of change in SET vs. EFT for depression: study protocol for a mechanistic randomized controlled trial. BMC Psychiatry. 2021 Jun 2;21(1):287. doi: 10.1186/s12888-021-03279-y.

MeSH Terms

Conditions

Depressive Disorder, Major

Condition Hierarchy (Ancestors)

Depressive DisorderMood DisordersMental Disorders

Central Study Contacts

Sigal Zilcha-Mano, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Double Blind (participants, outcome assessor)
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: A randomized controlled trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

September 26, 2020

First Posted

October 6, 2020

Study Start

November 29, 2020

Primary Completion (Estimated)

November 30, 2026

Study Completion (Estimated)

May 31, 2027

Last Updated

May 7, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will not share

Data will not be shared due to ethical reasons.

Locations